Two Sigma Securities’s VanEck Pharmaceutical ETF PPH Stock Holding History

Two Sigma Securities’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$850K	Sell	7,770 -14,291	-65%	-$1.48M	0.07%	344
2026 Q1	$2.29M	Buy	+22,061	New	+$2.35M	0.27%	65
2025 Q3	–	Sell	-4,480	Closed	-$394K	–	1878
2025 Q2	$394K	Buy	4,480 +1,282	+40%	+$111K	0.05%	536
2025 Q1	$291K	Buy	+3,198	New	+$288K	0.04%	605
2023 Q2	–	Sell	-3,771	Closed	-$293K	–	3222
2023 Q1	$293K	Buy	+3,771	New	+$291K	0.01%	1731
2022 Q4	–	Sell	-4,319	Closed	-$290K	–	3116
2022 Q3	$290K	Buy	+4,319	New	+$318K	0.01%	1608
2021 Q2	–	Sell	-3,178	Closed	-$219K	–	1660
2021 Q1	$219K	Buy	+3,178	New	+$219K	0.01%	603
2018 Q3	–	Sell	-4,483	Closed	-$264K	–	2921
2018 Q2	$264K	Buy	+4,483	New	+$260K	﹤0.01%	2155
2018 Q1	–	Sell	-6,294	Closed	-$374K	–	2893
2017 Q4	$374K	Buy	+6,294	New	+$361K	0.01%	866
2017 Q1	–	Sell	-4,273	Closed	-$224K	–	1070
2016 Q4	$224K	Buy	4,273 +303	+8%	+$16.2K	0.07%	379
2016 Q3	$228K	Buy	+3,970	New	+$238K	0.08%	391

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

Adamsbrown Wealth Consultants Wichita, Kansas $548M AUM 16.52% 1-Year Est. Return

Two Sigma Securities's PPH Position: Q2 2026 in Review

Two Sigma Securities reduced its VanEck Pharmaceutical ETF (PPH) stake by 65% in Q2 2026, selling an estimated $1.48M and leaving 7,770 shares worth $850K. The position accounts for 0.07% of the portfolio, ranked #344.

Two Sigma Securities first reported a position in PPH in Q3 2016 and has held it in 11 quarters since. The position peaked at $2.29M in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Two Sigma Securities held 7,770 shares of VanEck Pharmaceutical ETF worth $850K as of Q2 2026.
Two Sigma Securities sold 14,291 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $1.48M.
VanEck Pharmaceutical ETF made up 0.07% of Two Sigma Securities's portfolio in Q2 2026, its #344 holding.
Two Sigma Securities first reported a position in VanEck Pharmaceutical ETF in Q3 2016 and has held it in 11 quarters since.
Two Sigma Securities's VanEck Pharmaceutical ETF position peaked at $2.29M in Q1 2026.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.